NCT01828112
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01828112
Title LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | NLD | LBN | ITA | ISR | IRL | GBR | FRA | ESP | DEU | CHE | CAN | BEL

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Memorial Cancer Institute Hollywood Florida 33021 United States Details
Cancer Specialists of North Florida Jacksonville Florida 32256 United States Details
University Of Miami Miami Florida 33136 United States Details
Loyola University Medical Center Marywood Illinois 60153 United States Details
Uni Of Iowa Hospitals And Clinics Iowa City Iowa 52242 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Oklahoma Cancer Specialists and Research Institute Tulsa Oklahoma 74136 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Texas Oncology-Sugarland Sugar Land Texas 77479 United States Details
Texas Oncology Cancer Care and Research Center Waco Texas 76712 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
Novartis Investigative Site Brussels 1000 Belgium Details
Novartis Investigative Site Brussels 1200 Belgium Details
Novartis Investigative Site Edegem 2650 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Marseille Bouches Du Rhone 13915 France Details
Novartis Investigative Site Besançon 25030 France Details
Novartis Investigative Site Brest 29609 France Details
Novartis Investigative Site Caen 14021 France Details
Novartis Investigative Site Le Mans 72000 France Details
Novartis Investigative Site Mulhouse 68070 France Details
Novartis Investigative Site Paris 75970 France Details
Novartis Investigative Site Strasbourg F 67085 France Details
Novartis Investigative Site Suresnes 92150 France Details
Novartis Investigative Site Bad Berka 99438 Germany Details
Novartis Investigative Site Cologne 51109 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Esslingen am Neckar 73730 Germany Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Pokfulam Hong Kong Details
Novartis Investigative Site Limerick Co Limerick V94 YX29 Ireland Details
Novartis Investigative Site Dublin DO4 Ireland Details
Novartis Investigative Site Kfar Saba 44281 Israel Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Avellino AV 83100 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Milan MI 20132 Italy Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Pisa PI 56124 Italy Details
Novartis Investigative Site Aviano PN 33081 Italy Details
Novartis Investigative Site Reggio Emilia RE 42123 Italy Details
Novartis Investigative Site Roma RM 00189 Italy Details
Novartis Investigative Site Orbassano TO 10043 Italy Details
Novartis Investigative Site Verona VR 37126 Italy Details
Novartis Investigative Site Nagoya Aichi-ken 464 8681 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Fukuoka Fukuoka 811-1395 Japan Details
Novartis Investigative Site Fukuoka Fukuoka 812-8582 Japan Details
Novartis Investigative Site Akashi Hyōgo 673-8558 Japan Details
Novartis Investigative Site Okayama Okayama-ken 700-8558 Japan Details
Novartis Investigative Site Hirakata Osaka 573-1191 Japan Details
Novartis Investigative Site Osaka Osaka 541-8567 Japan Details
Novartis Investigative Site Ōsaka-sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Takatsuki Osaka 569-8686 Japan Details
Novartis Investigative Site Koto Ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Niigata 951 8520 Japan Details
Novartis Investigative Site El Achrafiyé 166830 Lebanon Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Lisbon 1649 035 Portugal Details
Novartis Investigative Site Moscow 115478 Russia Details
Novartis Investigative Site Moscow Region Istra Village 143423 Russia Details
Novartis Investigative Site Saint Petersburg 197022 Russia Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Seoul Seocho Gu 06591 South Korea Details
Novartis Investigative Site Seoul 03080 South Korea Details
Novartis Investigative Site Seoul 03722 South Korea Details
Novartis Investigative Site Seoul 05505 South Korea Details
Novartis Investigative Site Seoul 06351 South Korea Details
Novartis Investigative Site Seville Andalusia 41009 Spain Details
Novartis Investigative Site Seville Andalusia 41013 Spain Details
Novartis Investigative Site Barcelona Catalonia 08028 Spain Details
Novartis Investigative Site Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site A Coruña Galicia 15006 Spain Details
Novartis Investigative Site Santiago de Compostela Galicia 15706 Spain Details
Novartis Investigative Site Valencia Valencia 46010 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Madrid 28222 Spain Details
Novartis Investigative Site Lucerne 6000 Switzerland Details
Novartis Investigative Site Sankt Gallen 9007 Switzerland Details
Novartis Investigative Site Pendik Istanbul Turkey 34899 Turkey (Türkiye) Details
Novartis Investigative Site Istanbul TUR 34098 Turkey (Türkiye) Details
Novartis Investigative Site Ankara 06230 Turkey (Türkiye) Details
Novartis Investigative Site Cheltenham Gloucestershire GL53 7AN United Kingdom Details
Novartis Investigative Site Aberdeen Grampian Region AB25 2ZN United Kingdom Details
Novartis Investigative Site Leicester LE1 5WW United Kingdom Details
Novartis Investigative Site London SE1 9RT United Kingdom Details
Novartis Investigative Site Southampton SO30 3JB United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field